Signaling can be uncoupled from imaging of the somatostatin receptor type 2

Molecular Imaging

Volumn 6, Issue 6, 2007, Pages 427-437

  Han, Lin ^a   Yang, Dan ^a   Kundra, Vikas ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUSION PROTEIN; POLYMERASE CHAIN REACTION; SOMATOSTATIN RECEPTORS;

BIOLOGICAL ORGANS; CELL CULTURE; ENZYME ACTIVITY; LIGANDS; PROTEINS; TUMORS;

IMAGING SYSTEMS;

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; MUTANT PROTEIN; OCTREOTIDE; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR 2;

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; CELL CULTURE; DRUG EFFECT; EVALUATION; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MITOSIS; MOUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; PHYSIOLOGY; PROTEIN BINDING; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; MICE, NUDE; MITOSIS; MUTANT PROTEINS; NEOPLASM TRANSPLANTATION; OCTREOTIDE; PROTEIN BINDING; RADIOPHARMACEUTICALS; RECEPTORS, SOMATOSTATIN; SIGNAL TRANSDUCTION; SOMATOSTATIN; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 37649015741     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2007.00038     Document Type: Article

References (46)

1. John M, Meyerhof W, Richter D, et al. Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2. Gut 1996;38:33-9.
2. Termanini B, Gibril F, Reynolds JC, et al. Value of somatostatin receptor scintigraphy: a prospective study in gastrinoma of its effect on clinical management. Gastroenterology 1997;112:335-47.
3. Lamberts SW, Hofland LJ, Nobels FR. Neuroendocrine tumor markers. Front Neuroendocrinol 2001;22:309-39.
4. Kwekkeboom D, Krenning EP, de Jong M. Peptide receptor imaging and therapy. J Nucl Med 2000;41:1704-13.
5. Nikou GC, Lygidakis NJ, Toubanakis C, et al. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues. Hepatogastroenterology 2005;52:731-41.
6. Ducreux M, Ruszniewski P, Chayvialle JA, et al. The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors. Am J Gastroenterol 2000;95:3276-81.
7. Wymenga AN, Eriksson B, Salmela PI, et al. Efficacy and safety of prolonged-release lanreotide in patients with gastrointestinal neuroendocrine tumors and hormone-related symptoms. J Clin Oncol 1999;17:1111.
8. Petersenn S, Rasch AC, Presch S, et al. Genomic structure and transcriptional regulation of the human somatostatin receptor type 2, Mol Cell Endocrinol 1999;157:75-85.
9. Schwartkop CP, Kreienkamp HJ, Richter D. Agonist-independent internalization and activity of a C-terminally truncated somatostatin receptor subtype 2 (delta349). J Neurochem 1999;72:1275-82.
10. Lopez F, Ferjoux G, Cordelier P, et al. Neuronal nitric oxide synthase: a substrate for SHP-I involved in sst2 somatostatin receptor growth inhibitory signaling. Faseb J 2001;15:2300-2.
11. Kluxen FW, Bruns C, Lubbert H. Expression cloning of a rat brain somatostatin receptor cDNA. Proc Natl Acad Sci U S A 1992;89: 4618-22.
12. Bell GI, Reisine T. Molecular biology of somatostatin receptors. Trends Neurosci 1993;16:34-8.
13. Panetta R, Greenwood MT, Warszynska A, et al. Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28. Mol Pharmacol 1994;45:417-27.
14. O'Carroll AM, Lolait SJ, König M, Mahan LC. Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin: 28. Mol Pharmacol 1993;44: 1278.
15. Yamada Y, Reisine T, Law SF, et al. Somatostatin receptors, an expanding gene family: cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase. Mol Endocrinol 1992;6:2136-42.
16. Yang D, Han L, Kundra V. Exogenous gene expression in tumors: noninvasive quantification with functional and anatomic imaging in a mouse model. Radiology 2005;235:950-8.
17. Lebtahi R, Le Cloirec J, Houzard C, et al. Detection of neuroendocrine tumors: 99mTc-P829 scintigraphy compared with 111In-pentetreotide scintigraphy. J Nud Med 2002;43:889-95.
18. Schmitt A, Bernhardt P, Nilsson O, et al. Differences in biodistribution between 99mTc-depreotide, 111In-DTPA-octreotide, and 177Lu-DOTA-Tyr3-octreotate in a small cell lung cancer animal model. Cancer Biother Radiopharm 2005;20:231-6.
19. Virgolini I, Leimer M, Handmaker H, et al. Somatostatin receptor subtype specificity and in vivo binding of a novel tumor tracer, 99mTc-P829. Cancer Res 1998;58:1850-9.
20. Krenning EP, Bakker WH, Kooij PP, et al. Somatostatin receptor scintigraphy with indium- 111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide. I Nucl Med 1992;33:652-8.
21. Pomper MG, VanBrocklin H, Thieme AM, et al. 11 Beta-methoxy-, 11 beta-ethyl- and 17 alpha-ethynyl-substituted 16 alphafluoroestradiols: receptor-based imaging agents with enhanced uptake efficiency and selectivity. J Med Chem 1990;33:3143-55.
22. Hukovic N, Panetta R, Kumar U, et al. The cytoplasmic tail of the human somatostatin receptor type 5 is crucial for interaction with adenylyl cyclase and in mediating desensitization and internalization. J Biol Chem 1998;273:21416-22.
23. Kundra V, Mannting F, Jones AG, Kassis AI. Noninvasive monitoring of somatostatin receptor type 2 chimeric gene transfer. J Nucl Med 2002;43:406-12.
24. Panetta R, Patel YC. Expression of mRNA for all five human somatostatin receptors (hSSTR1-5) in pituitary tumors. Life Sci 1995;56:333-42.
25. Birzin ET, Rohrer SP. High-throughput receptor-binding methods for somatostatin receptor 2. Anal Biochem 2002;307:159-66.
26. Sandler LM, Burrin JM, Williams G, et al. Effective long-term treatment of acromegaly with a long-acting somatostatin analogue (SMS 201-995). Clin Endocrinol (Oxf) 1987;26:85-95.
27. Bauer W, Briner U, Doepfner W, et al. SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action, Life Sci 1982;31:1133-40.
28. Tada H, Shiho O, Kuroshima K, et al. An improved colorimetric assay for interleukin 2. J Immunol Methods 1986;93:157-65.
29. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
30. Kahler CM, Herold M, Reinisch N, Wiedermann CJ. Interaction of substance P with epidermal growth factor and fibroblast growth factor in cyclooxygenase-dependent proliferation of human skin fibroblasts. J Cell Physiol 1996;166:601-8.
31. Colleselli D, Bijuklic K, Mosheimer BA, Kahler CM. Inhibition of cyclooxygenase (COX)-2 affects endothelial progenitor cell proliferation. Exp Cell Res 2006;312:2933-41.
32. Kreienkamp HJ, Roth A, Richter D. Rat somatostatin receptor subtype 4 can be made sensitive to agonist-induced internalization by mutation of a single threonine (residue 331). DNA Cell Biol 1998;17:869-78.
33. Tomura H, Okajima F, Akbar M, et al. Transfected human somatostatin receptor type 2, SSTR2, not only inhibits adenylate cyclase but also stimulates phospholipase C and Ca2+ mobilization. Biochem Biophys Res Commun 1994;200:986-92.
34. Strowski MZ, Dashkevicz MP, Parmar RM, et al. Somatostatin receptor subtypes 2 and 5 inhibit corticotropin-releasing hormonestimulated adrenocorticotropin secretion from AtT-20 cells. Neuroendocrinology 2002;75:339-46.
35. Gong AY, Tietz PS, Muff MA, et al. Somatostatin stimulates ductal bile absorption and inhibits ductal bile secretion in mice via SSTR2 on cholangiocytes. Am J Physiol Cell Physiol 2003;284:C1205-14.
36. Grilli M, Raiteri L, Pittaluga A. Somatostatin inhibits glutamate release from mouse cerebrocortical nerve endings through presynaptic sst2 receptors linked to the adenylyl cyclase-protein kinase A pathway. Neuropharmacology 2004;46:388-96.
37. Oomen SP, van Hennik PB, Antonissen C, et al. Somatostatin is a selective chemoattractant for primitive (CD34(+)) hematopoietic progenitor cells. Exp Hematol 2002;30:116-25.
38. Liang Q, Satyamurthy N, Barrio JR, et al. Noninvasive, quantitative imaging in living animals of a mutant dopamine D2 receptor reporter gene in which ligand binding is uncoupled from signal transduction. Gene Ther 2001;8:1490-8.
39. Thangaraju M, Sharma K, Leber B, et al. Regulation of acidification and apoptosis by SHP-I and Bcl-2. J Biol Chem 1999;274:29549-57.
40. Lahlou H, Saint-Laurent N, Esteve JP, et al. sst2 Somatostatin receptor inhibits cell proliferation through Ras-, Rapl-, and B-Rafdependent ERK2 activation. J Biol Chem 2003;278:39356-71.
41. Cattaneo MG, Taylor JE, Culler MD, et al. Selective stimulation of somatostatin receptor subtypes: differential effects on Ras/MAP kinase pathway and cell proliferation in human neuroblastoma cells. FEBS Lett 2000;481:271-6.
42. Zhao B. Cholangiocarcinoma cells express SSTR2 and respond to OCT. J Hepatobiliary Pancreat Surg 2002;9:497-502.
43. Tjuvajev JG, Stockhammer G, Desai R, et al. Imaging the expression of transfected genes in vivo. Cancer Res 1995;55: 6126-32.
44. Gambhir SS, Barrio JR, Wu L, et al. Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled gancidovir. J Nucl Med 1998; 39:2003-11.
45. Mandell RB, Mandell LZ, Link CJ Jr. Radioisotope concentrator gene therapy using the sodium/iodide symporter gene. Cancer Res 1999;59:661-8.
46. Zinn KR, Buchsbaum DJ, Chaudhuri TR, et al. Noninvasive monitoring of gene transfer using a reporter receptor imaged with a high-affinity peptide radiolabeled with 99mTc or 188Re. J Nud Med 2000;41:887-95.